Prognostic Value of Mean Platelet Volume in Septic Shock: A Retrospective Cohort Study

Background

Mean platelet volume (MPV) is a simple, low-cost biomarker that reflects platelet activation. Its prognostic value in septic shock remains controversial. We aimed to determine whether MPV at intensive care unit (ICU) admission is associated with hospital mortality in patients with septic shock.

Methods

Retrospective cohort study of consecutive adults with septic shock (Sepsis-3 criteria) admitted to a single ICU. MPV, severity scores (SOFA, APACHE II, SAPS II), procalcitonin, and clinical data were collected. The primary outcome was in-hospital mortality. Spearman correlation, univariate and multivariate logistic regression (with Firth’s correction), ROC curves, and subgroup analyses were performed.

Results

Fifty-eight patients were included; mortality was 58.6%. MPV did not differ between non-survivors and survivors (13.09 ± 1.37 vs. 12.66 ± 1.45 fL, p = 0.259). MPV showed a weak correlation with procalcitonin ( ρ = 0.394, p = 0.002) but not with severity scores. In multivariate analysis adjusting for age, sex, SOFA and comorbidity count, MPV was not an independent predictor of mortality (OR 1.075, 95% CI 0.682–1.755, p = 0.749). The area under the ROC curve for MPV was 0.598 (95% CI 0.444–0.752), significantly lower than that of SOFA (0.837) and procalcitonin (0.836). Sub-group analyses showed no significant association between MPV and mortality in any stratum.

Conclusions

In this cohort of septic shock patients, MPV at ICU admission was not associated with hospital mortality and had poor discriminative ability. Widely used severity scores and procalcitonin remain superior prognostic markers. MPV should not be used as a prognostic tool in septic shock.

Highlights